SRx Health Solutions Receives Late Filing Notification Letter From NYSE

SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that on August 20, 2025, it received an official notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (the "Exchange") as set forth in Section 1007 of the NYSE American Company Guide. The notice was issued because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the "Delinquent Report") with the Securities and Exchange Commission (the "SEC") by the required due date of August 19, 2025.

During the six-month period from the date of the Filing Delinquency (the "Initial Cure Period"), the Exchange will monitor the Issuer and the status of the Delinquent Report and any subsequent delayed filings, including through contact with the Issuer, until the Filing Delinquency is cured. If the Issuer fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in the Exchange's sole discretion, allow the Issuer's securities to be traded for up to an additional six-month period (the "Additional Cure Period") depending on the Issuer's specific circumstances.

The Company is working diligently with its auditors and advisors to complete the Delinquent Report as soon as practicable. The Company is currently anticipating filing the Delinquent Report on or before the cure period deadline.

This notice does not immediately affect the listing or trading of the Company's common stock on the Exchange. The Company intends to regain compliance with the Exchange's listing standards. While there can be no assurance that it will regain compliance with all applicable Exchange listing standards, the Company is confident it will comply with all listing standards.